Global Patient Blood Management Market

Patient Blood Management Comprehensive Study by Type (Transfusion Device, Accessories, Software, Reagents and Kits, Others), Application (Hospitals, Blood Banks, Pathology Labs, Others), Components (Whole Blood, Plasma), Services (Surgical {Pre-operative, Intra-operative, Post-operative}, Medical {Abnormal Hemostasis, Anaemia}), System (Whole Blood Collection, Component Collection System, Automated Blood Processing System, Pathogen Reduction System, Others) Players and Region - Global Market Outlook to 2027

Patient Blood Management Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Patient Blood Management
Patient Blood Management (PBM) includes all aspects of the patient evaluation as it is the evidence-based multidisciplinary approach for optimizing the care of patients who need a transfusion. It also includes the clinical management associated transfusion process along with the application of appropriate diagnosis and minimization of blood loss. PBM decreases the need for allogeneic blood transfusions by ensuring the blood components required available in the patients lowering the risk of acute kidney damage for the operated patient. According to the study with 130,000 patients, it proved to be a benefit for patients, over more than 100 hospitals across Germany are working on the introduction of the PBM concept

AttributesDetails
Study Period2017-2027
Base Year2021
UnitValue (USD Million)


Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

B. Braun (Germany), Haemonetics Corporation (United States), Terumo Corporation (Japan), Mediware Information Systems (United States), Bio-Rad Laboratories, Inc. (United States), LivaNova, PLC (United Kingdom), Stratec Biomedical Systems (Diatron) (Germany), Accumen Inc. (United States), BioMerieux (France), Asahi Kasei Corporation (Japan), Grifols, S.A. (Spain) and Immucor, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Kawasumi Laboratories, Inc. (Japan) and Fresenius SE & Co. KGaA (Germany).

Segmentation Overview
AMA Research has segmented the market of Global Patient Blood Management market by Type (Transfusion Device, Accessories, Software, Reagents and Kits and Others), Application (Hospitals, Blood Banks, Pathology Labs and Others) and Region.



On the basis of geography, the market of Patient Blood Management has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2021. If we see Market by Components, the sub-segment i.e. Whole Blood will boost the Patient Blood Management market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Services, the sub-segment i.e. Surgical {Pre-operative, Intra-operative, Post-operative} will boost the Patient Blood Management market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by System, the sub-segment i.e. Whole Blood Collection will boost the Patient Blood Management market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Leaders and their expansionary development strategies
On 19th August 2019, Accumen Inc. acquired the Patient Readiness Institutes offering MyBloodHealth for bringing virtual preoperative anemia management solutions scaled for hospitals of any size to Acumen clients. This technology will allow Acumen's clients to bring a data-driven preoperative anemia approach to the patients.
On 5th December 2019, Haemonetics announced the commercial launch of the next generation of its SafeTrace TX transfusion management software (blood management) in North America. The product is a specialized transfusion management system used in the blood bank for managing patient and blood product data and assisting in determining the blood product suitability for patient transfusion. and The software ensures the safety of patient transfusion of blood by guarding against the mistakes and protecting it from the errors with improved data visualizations.
"The NSQHS Standards Blood Management Standard aims to ensure that patients who receive blood and blood products do so appropriately and safely. Patient Blood Management (PBM) is a multidisciplinary approach that promotes appropriate care for patients and reduces exposure to unnecessary blood transfusions. To reduce unnecessary clinical variation and morbidity and mortality associated with preoperative anaemia, the Commission has established the National Patient Blood Management Collaborative (the Collaborative). A systematic review has identified an independent association between pre-operative anaemia and increase morbidity and mortality, and an increased likelihood of red blood cell (RBC) transfusion. As pre-operative anaemia management could reduce RBC transfusions and reduce post-surgery morbidity, mortality and length-of-stay in hospital."

Market Drivers
  • There is a growing need for safety enhancement in blood-related product management due to the increasing prevalence of blood-related disease and road accidents for the timely availability of blood. It also includes proper management of other systems and services associated with patients' treatment.

Opportunities
  • Introduction of Patient Blood Management Programs Across the Country
  • Surging Spendings on Healthcare Industry

Restraints
  • The Risk of Adverse Effects on Blood Transfusion
  • Regulatory Norms Involved with Patient Blood Management

Challenges
  • Less Awareness in Many Rural Areas of the World


Key Target Audience
Blood Devices and Accessories Manufacturers, Industry Associations, Regulatory Bodies, Hospitals, Software Providers, Pathology Laboratories, Potential Investors and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.

Report Objectives / Segmentation Covered

By Type
  • Transfusion Device
  • Accessories
  • Software
  • Reagents and Kits
  • Others
By Application
  • Hospitals
  • Blood Banks
  • Pathology Labs
  • Others
By Components
  • Whole Blood
  • Plasma

By Services
  • Surgical {Pre-operative, Intra-operative, Post-operative}
  • Medical {Abnormal Hemostasis, Anaemia}

By System
  • Whole Blood Collection
  • Component Collection System
  • Automated Blood Processing System
  • Pathogen Reduction System
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. There is a growing need for safety enhancement in blood-related product management due to the increasing prevalence of blood-related disease and road accidents for the timely availability of blood. It also includes proper management of other systems and services associated with patients' treatment.
    • 3.3. Market Challenges
      • 3.3.1. Less Awareness in Many Rural Areas of the World
    • 3.4. Market Trends
      • 3.4.1. The Increasing Trend of Remote Patient Monitoring in Patient Blood Management
      • 3.4.2. Continuous Improvement in Technologies Used in Patient Blood Management
      • 3.4.3. Adoption of Software Technologies for Patient Blood Management
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Patient Blood Management, by Type, Application, Components, Services, System and Region (value) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Patient Blood Management (Value)
      • 5.2.1. Global Patient Blood Management by: Type (Value)
        • 5.2.1.1. Transfusion Device
        • 5.2.1.2. Accessories
        • 5.2.1.3. Software
        • 5.2.1.4. Reagents and Kits
        • 5.2.1.5. Others
      • 5.2.2. Global Patient Blood Management by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Blood Banks
        • 5.2.2.3. Pathology Labs
        • 5.2.2.4. Others
      • 5.2.3. Global Patient Blood Management by: Components (Value)
        • 5.2.3.1. Whole Blood
        • 5.2.3.2. Plasma
      • 5.2.4. Global Patient Blood Management by: Services (Value)
        • 5.2.4.1. Surgical {Pre-operative, Intra-operative, Post-operative}
        • 5.2.4.2. Medical {Abnormal Hemostasis, Anaemia}
      • 5.2.5. Global Patient Blood Management by: System (Value)
        • 5.2.5.1. Whole Blood Collection
        • 5.2.5.2. Component Collection System
        • 5.2.5.3. Automated Blood Processing System
        • 5.2.5.4. Pathogen Reduction System
        • 5.2.5.5. Others
      • 5.2.6. Global Patient Blood Management Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Patient Blood Management: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. B. Braun (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Haemonetics Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Terumo Corporation (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Mediware Information Systems (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. LivaNova, PLC (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Stratec Biomedical Systems (Diatron) (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Accumen Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. BioMerieux (France)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Asahi Kasei Corporation (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Grifols, S.A. (Spain)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Immucor, Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Patient Blood Management Sale, by Type, Application, Components, Services, System and Region (value) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Patient Blood Management (Value)
      • 7.2.1. Global Patient Blood Management by: Type (Value)
        • 7.2.1.1. Transfusion Device
        • 7.2.1.2. Accessories
        • 7.2.1.3. Software
        • 7.2.1.4. Reagents and Kits
        • 7.2.1.5. Others
      • 7.2.2. Global Patient Blood Management by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Blood Banks
        • 7.2.2.3. Pathology Labs
        • 7.2.2.4. Others
      • 7.2.3. Global Patient Blood Management by: Components (Value)
        • 7.2.3.1. Whole Blood
        • 7.2.3.2. Plasma
      • 7.2.4. Global Patient Blood Management by: Services (Value)
        • 7.2.4.1. Surgical {Pre-operative, Intra-operative, Post-operative}
        • 7.2.4.2. Medical {Abnormal Hemostasis, Anaemia}
      • 7.2.5. Global Patient Blood Management by: System (Value)
        • 7.2.5.1. Whole Blood Collection
        • 7.2.5.2. Component Collection System
        • 7.2.5.3. Automated Blood Processing System
        • 7.2.5.4. Pathogen Reduction System
        • 7.2.5.5. Others
      • 7.2.6. Global Patient Blood Management Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Patient Blood Management: by Type(USD Million)
  • Table 2. Patient Blood Management Transfusion Device , by Region USD Million (2016-2021)
  • Table 3. Patient Blood Management Accessories , by Region USD Million (2016-2021)
  • Table 4. Patient Blood Management Software , by Region USD Million (2016-2021)
  • Table 5. Patient Blood Management Reagents and Kits , by Region USD Million (2016-2021)
  • Table 6. Patient Blood Management Others , by Region USD Million (2016-2021)
  • Table 7. Patient Blood Management: by Application(USD Million)
  • Table 8. Patient Blood Management Hospitals , by Region USD Million (2016-2021)
  • Table 9. Patient Blood Management Blood Banks , by Region USD Million (2016-2021)
  • Table 10. Patient Blood Management Pathology Labs , by Region USD Million (2016-2021)
  • Table 11. Patient Blood Management Others , by Region USD Million (2016-2021)
  • Table 12. Patient Blood Management: by Components(USD Million)
  • Table 13. Patient Blood Management Whole Blood , by Region USD Million (2016-2021)
  • Table 14. Patient Blood Management Plasma , by Region USD Million (2016-2021)
  • Table 15. Patient Blood Management: by Services(USD Million)
  • Table 16. Patient Blood Management Surgical {Pre-operative, Intra-operative, Post-operative} , by Region USD Million (2016-2021)
  • Table 17. Patient Blood Management Medical {Abnormal Hemostasis, Anaemia} , by Region USD Million (2016-2021)
  • Table 18. Patient Blood Management: by System(USD Million)
  • Table 19. Patient Blood Management Whole Blood Collection , by Region USD Million (2016-2021)
  • Table 20. Patient Blood Management Component Collection System , by Region USD Million (2016-2021)
  • Table 21. Patient Blood Management Automated Blood Processing System , by Region USD Million (2016-2021)
  • Table 22. Patient Blood Management Pathogen Reduction System , by Region USD Million (2016-2021)
  • Table 23. Patient Blood Management Others , by Region USD Million (2016-2021)
  • Table 24. South America Patient Blood Management, by Country USD Million (2016-2021)
  • Table 25. South America Patient Blood Management, by Type USD Million (2016-2021)
  • Table 26. South America Patient Blood Management, by Application USD Million (2016-2021)
  • Table 27. South America Patient Blood Management, by Components USD Million (2016-2021)
  • Table 28. South America Patient Blood Management, by Services USD Million (2016-2021)
  • Table 29. South America Patient Blood Management, by System USD Million (2016-2021)
  • Table 30. Brazil Patient Blood Management, by Type USD Million (2016-2021)
  • Table 31. Brazil Patient Blood Management, by Application USD Million (2016-2021)
  • Table 32. Brazil Patient Blood Management, by Components USD Million (2016-2021)
  • Table 33. Brazil Patient Blood Management, by Services USD Million (2016-2021)
  • Table 34. Brazil Patient Blood Management, by System USD Million (2016-2021)
  • Table 35. Argentina Patient Blood Management, by Type USD Million (2016-2021)
  • Table 36. Argentina Patient Blood Management, by Application USD Million (2016-2021)
  • Table 37. Argentina Patient Blood Management, by Components USD Million (2016-2021)
  • Table 38. Argentina Patient Blood Management, by Services USD Million (2016-2021)
  • Table 39. Argentina Patient Blood Management, by System USD Million (2016-2021)
  • Table 40. Rest of South America Patient Blood Management, by Type USD Million (2016-2021)
  • Table 41. Rest of South America Patient Blood Management, by Application USD Million (2016-2021)
  • Table 42. Rest of South America Patient Blood Management, by Components USD Million (2016-2021)
  • Table 43. Rest of South America Patient Blood Management, by Services USD Million (2016-2021)
  • Table 44. Rest of South America Patient Blood Management, by System USD Million (2016-2021)
  • Table 45. Asia Pacific Patient Blood Management, by Country USD Million (2016-2021)
  • Table 46. Asia Pacific Patient Blood Management, by Type USD Million (2016-2021)
  • Table 47. Asia Pacific Patient Blood Management, by Application USD Million (2016-2021)
  • Table 48. Asia Pacific Patient Blood Management, by Components USD Million (2016-2021)
  • Table 49. Asia Pacific Patient Blood Management, by Services USD Million (2016-2021)
  • Table 50. Asia Pacific Patient Blood Management, by System USD Million (2016-2021)
  • Table 51. China Patient Blood Management, by Type USD Million (2016-2021)
  • Table 52. China Patient Blood Management, by Application USD Million (2016-2021)
  • Table 53. China Patient Blood Management, by Components USD Million (2016-2021)
  • Table 54. China Patient Blood Management, by Services USD Million (2016-2021)
  • Table 55. China Patient Blood Management, by System USD Million (2016-2021)
  • Table 56. Japan Patient Blood Management, by Type USD Million (2016-2021)
  • Table 57. Japan Patient Blood Management, by Application USD Million (2016-2021)
  • Table 58. Japan Patient Blood Management, by Components USD Million (2016-2021)
  • Table 59. Japan Patient Blood Management, by Services USD Million (2016-2021)
  • Table 60. Japan Patient Blood Management, by System USD Million (2016-2021)
  • Table 61. India Patient Blood Management, by Type USD Million (2016-2021)
  • Table 62. India Patient Blood Management, by Application USD Million (2016-2021)
  • Table 63. India Patient Blood Management, by Components USD Million (2016-2021)
  • Table 64. India Patient Blood Management, by Services USD Million (2016-2021)
  • Table 65. India Patient Blood Management, by System USD Million (2016-2021)
  • Table 66. South Korea Patient Blood Management, by Type USD Million (2016-2021)
  • Table 67. South Korea Patient Blood Management, by Application USD Million (2016-2021)
  • Table 68. South Korea Patient Blood Management, by Components USD Million (2016-2021)
  • Table 69. South Korea Patient Blood Management, by Services USD Million (2016-2021)
  • Table 70. South Korea Patient Blood Management, by System USD Million (2016-2021)
  • Table 71. Taiwan Patient Blood Management, by Type USD Million (2016-2021)
  • Table 72. Taiwan Patient Blood Management, by Application USD Million (2016-2021)
  • Table 73. Taiwan Patient Blood Management, by Components USD Million (2016-2021)
  • Table 74. Taiwan Patient Blood Management, by Services USD Million (2016-2021)
  • Table 75. Taiwan Patient Blood Management, by System USD Million (2016-2021)
  • Table 76. Australia Patient Blood Management, by Type USD Million (2016-2021)
  • Table 77. Australia Patient Blood Management, by Application USD Million (2016-2021)
  • Table 78. Australia Patient Blood Management, by Components USD Million (2016-2021)
  • Table 79. Australia Patient Blood Management, by Services USD Million (2016-2021)
  • Table 80. Australia Patient Blood Management, by System USD Million (2016-2021)
  • Table 81. Rest of Asia-Pacific Patient Blood Management, by Type USD Million (2016-2021)
  • Table 82. Rest of Asia-Pacific Patient Blood Management, by Application USD Million (2016-2021)
  • Table 83. Rest of Asia-Pacific Patient Blood Management, by Components USD Million (2016-2021)
  • Table 84. Rest of Asia-Pacific Patient Blood Management, by Services USD Million (2016-2021)
  • Table 85. Rest of Asia-Pacific Patient Blood Management, by System USD Million (2016-2021)
  • Table 86. Europe Patient Blood Management, by Country USD Million (2016-2021)
  • Table 87. Europe Patient Blood Management, by Type USD Million (2016-2021)
  • Table 88. Europe Patient Blood Management, by Application USD Million (2016-2021)
  • Table 89. Europe Patient Blood Management, by Components USD Million (2016-2021)
  • Table 90. Europe Patient Blood Management, by Services USD Million (2016-2021)
  • Table 91. Europe Patient Blood Management, by System USD Million (2016-2021)
  • Table 92. Germany Patient Blood Management, by Type USD Million (2016-2021)
  • Table 93. Germany Patient Blood Management, by Application USD Million (2016-2021)
  • Table 94. Germany Patient Blood Management, by Components USD Million (2016-2021)
  • Table 95. Germany Patient Blood Management, by Services USD Million (2016-2021)
  • Table 96. Germany Patient Blood Management, by System USD Million (2016-2021)
  • Table 97. France Patient Blood Management, by Type USD Million (2016-2021)
  • Table 98. France Patient Blood Management, by Application USD Million (2016-2021)
  • Table 99. France Patient Blood Management, by Components USD Million (2016-2021)
  • Table 100. France Patient Blood Management, by Services USD Million (2016-2021)
  • Table 101. France Patient Blood Management, by System USD Million (2016-2021)
  • Table 102. Italy Patient Blood Management, by Type USD Million (2016-2021)
  • Table 103. Italy Patient Blood Management, by Application USD Million (2016-2021)
  • Table 104. Italy Patient Blood Management, by Components USD Million (2016-2021)
  • Table 105. Italy Patient Blood Management, by Services USD Million (2016-2021)
  • Table 106. Italy Patient Blood Management, by System USD Million (2016-2021)
  • Table 107. United Kingdom Patient Blood Management, by Type USD Million (2016-2021)
  • Table 108. United Kingdom Patient Blood Management, by Application USD Million (2016-2021)
  • Table 109. United Kingdom Patient Blood Management, by Components USD Million (2016-2021)
  • Table 110. United Kingdom Patient Blood Management, by Services USD Million (2016-2021)
  • Table 111. United Kingdom Patient Blood Management, by System USD Million (2016-2021)
  • Table 112. Netherlands Patient Blood Management, by Type USD Million (2016-2021)
  • Table 113. Netherlands Patient Blood Management, by Application USD Million (2016-2021)
  • Table 114. Netherlands Patient Blood Management, by Components USD Million (2016-2021)
  • Table 115. Netherlands Patient Blood Management, by Services USD Million (2016-2021)
  • Table 116. Netherlands Patient Blood Management, by System USD Million (2016-2021)
  • Table 117. Rest of Europe Patient Blood Management, by Type USD Million (2016-2021)
  • Table 118. Rest of Europe Patient Blood Management, by Application USD Million (2016-2021)
  • Table 119. Rest of Europe Patient Blood Management, by Components USD Million (2016-2021)
  • Table 120. Rest of Europe Patient Blood Management, by Services USD Million (2016-2021)
  • Table 121. Rest of Europe Patient Blood Management, by System USD Million (2016-2021)
  • Table 122. MEA Patient Blood Management, by Country USD Million (2016-2021)
  • Table 123. MEA Patient Blood Management, by Type USD Million (2016-2021)
  • Table 124. MEA Patient Blood Management, by Application USD Million (2016-2021)
  • Table 125. MEA Patient Blood Management, by Components USD Million (2016-2021)
  • Table 126. MEA Patient Blood Management, by Services USD Million (2016-2021)
  • Table 127. MEA Patient Blood Management, by System USD Million (2016-2021)
  • Table 128. Middle East Patient Blood Management, by Type USD Million (2016-2021)
  • Table 129. Middle East Patient Blood Management, by Application USD Million (2016-2021)
  • Table 130. Middle East Patient Blood Management, by Components USD Million (2016-2021)
  • Table 131. Middle East Patient Blood Management, by Services USD Million (2016-2021)
  • Table 132. Middle East Patient Blood Management, by System USD Million (2016-2021)
  • Table 133. Africa Patient Blood Management, by Type USD Million (2016-2021)
  • Table 134. Africa Patient Blood Management, by Application USD Million (2016-2021)
  • Table 135. Africa Patient Blood Management, by Components USD Million (2016-2021)
  • Table 136. Africa Patient Blood Management, by Services USD Million (2016-2021)
  • Table 137. Africa Patient Blood Management, by System USD Million (2016-2021)
  • Table 138. North America Patient Blood Management, by Country USD Million (2016-2021)
  • Table 139. North America Patient Blood Management, by Type USD Million (2016-2021)
  • Table 140. North America Patient Blood Management, by Application USD Million (2016-2021)
  • Table 141. North America Patient Blood Management, by Components USD Million (2016-2021)
  • Table 142. North America Patient Blood Management, by Services USD Million (2016-2021)
  • Table 143. North America Patient Blood Management, by System USD Million (2016-2021)
  • Table 144. United States Patient Blood Management, by Type USD Million (2016-2021)
  • Table 145. United States Patient Blood Management, by Application USD Million (2016-2021)
  • Table 146. United States Patient Blood Management, by Components USD Million (2016-2021)
  • Table 147. United States Patient Blood Management, by Services USD Million (2016-2021)
  • Table 148. United States Patient Blood Management, by System USD Million (2016-2021)
  • Table 149. Canada Patient Blood Management, by Type USD Million (2016-2021)
  • Table 150. Canada Patient Blood Management, by Application USD Million (2016-2021)
  • Table 151. Canada Patient Blood Management, by Components USD Million (2016-2021)
  • Table 152. Canada Patient Blood Management, by Services USD Million (2016-2021)
  • Table 153. Canada Patient Blood Management, by System USD Million (2016-2021)
  • Table 154. Mexico Patient Blood Management, by Type USD Million (2016-2021)
  • Table 155. Mexico Patient Blood Management, by Application USD Million (2016-2021)
  • Table 156. Mexico Patient Blood Management, by Components USD Million (2016-2021)
  • Table 157. Mexico Patient Blood Management, by Services USD Million (2016-2021)
  • Table 158. Mexico Patient Blood Management, by System USD Million (2016-2021)
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Company Basic Information, Sales Area and Its Competitors
  • Table 171. Patient Blood Management: by Type(USD Million)
  • Table 172. Patient Blood Management Transfusion Device , by Region USD Million (2022-2027)
  • Table 173. Patient Blood Management Accessories , by Region USD Million (2022-2027)
  • Table 174. Patient Blood Management Software , by Region USD Million (2022-2027)
  • Table 175. Patient Blood Management Reagents and Kits , by Region USD Million (2022-2027)
  • Table 176. Patient Blood Management Others , by Region USD Million (2022-2027)
  • Table 177. Patient Blood Management: by Application(USD Million)
  • Table 178. Patient Blood Management Hospitals , by Region USD Million (2022-2027)
  • Table 179. Patient Blood Management Blood Banks , by Region USD Million (2022-2027)
  • Table 180. Patient Blood Management Pathology Labs , by Region USD Million (2022-2027)
  • Table 181. Patient Blood Management Others , by Region USD Million (2022-2027)
  • Table 182. Patient Blood Management: by Components(USD Million)
  • Table 183. Patient Blood Management Whole Blood , by Region USD Million (2022-2027)
  • Table 184. Patient Blood Management Plasma , by Region USD Million (2022-2027)
  • Table 185. Patient Blood Management: by Services(USD Million)
  • Table 186. Patient Blood Management Surgical {Pre-operative, Intra-operative, Post-operative} , by Region USD Million (2022-2027)
  • Table 187. Patient Blood Management Medical {Abnormal Hemostasis, Anaemia} , by Region USD Million (2022-2027)
  • Table 188. Patient Blood Management: by System(USD Million)
  • Table 189. Patient Blood Management Whole Blood Collection , by Region USD Million (2022-2027)
  • Table 190. Patient Blood Management Component Collection System , by Region USD Million (2022-2027)
  • Table 191. Patient Blood Management Automated Blood Processing System , by Region USD Million (2022-2027)
  • Table 192. Patient Blood Management Pathogen Reduction System , by Region USD Million (2022-2027)
  • Table 193. Patient Blood Management Others , by Region USD Million (2022-2027)
  • Table 194. South America Patient Blood Management, by Country USD Million (2022-2027)
  • Table 195. South America Patient Blood Management, by Type USD Million (2022-2027)
  • Table 196. South America Patient Blood Management, by Application USD Million (2022-2027)
  • Table 197. South America Patient Blood Management, by Components USD Million (2022-2027)
  • Table 198. South America Patient Blood Management, by Services USD Million (2022-2027)
  • Table 199. South America Patient Blood Management, by System USD Million (2022-2027)
  • Table 200. Brazil Patient Blood Management, by Type USD Million (2022-2027)
  • Table 201. Brazil Patient Blood Management, by Application USD Million (2022-2027)
  • Table 202. Brazil Patient Blood Management, by Components USD Million (2022-2027)
  • Table 203. Brazil Patient Blood Management, by Services USD Million (2022-2027)
  • Table 204. Brazil Patient Blood Management, by System USD Million (2022-2027)
  • Table 205. Argentina Patient Blood Management, by Type USD Million (2022-2027)
  • Table 206. Argentina Patient Blood Management, by Application USD Million (2022-2027)
  • Table 207. Argentina Patient Blood Management, by Components USD Million (2022-2027)
  • Table 208. Argentina Patient Blood Management, by Services USD Million (2022-2027)
  • Table 209. Argentina Patient Blood Management, by System USD Million (2022-2027)
  • Table 210. Rest of South America Patient Blood Management, by Type USD Million (2022-2027)
  • Table 211. Rest of South America Patient Blood Management, by Application USD Million (2022-2027)
  • Table 212. Rest of South America Patient Blood Management, by Components USD Million (2022-2027)
  • Table 213. Rest of South America Patient Blood Management, by Services USD Million (2022-2027)
  • Table 214. Rest of South America Patient Blood Management, by System USD Million (2022-2027)
  • Table 215. Asia Pacific Patient Blood Management, by Country USD Million (2022-2027)
  • Table 216. Asia Pacific Patient Blood Management, by Type USD Million (2022-2027)
  • Table 217. Asia Pacific Patient Blood Management, by Application USD Million (2022-2027)
  • Table 218. Asia Pacific Patient Blood Management, by Components USD Million (2022-2027)
  • Table 219. Asia Pacific Patient Blood Management, by Services USD Million (2022-2027)
  • Table 220. Asia Pacific Patient Blood Management, by System USD Million (2022-2027)
  • Table 221. China Patient Blood Management, by Type USD Million (2022-2027)
  • Table 222. China Patient Blood Management, by Application USD Million (2022-2027)
  • Table 223. China Patient Blood Management, by Components USD Million (2022-2027)
  • Table 224. China Patient Blood Management, by Services USD Million (2022-2027)
  • Table 225. China Patient Blood Management, by System USD Million (2022-2027)
  • Table 226. Japan Patient Blood Management, by Type USD Million (2022-2027)
  • Table 227. Japan Patient Blood Management, by Application USD Million (2022-2027)
  • Table 228. Japan Patient Blood Management, by Components USD Million (2022-2027)
  • Table 229. Japan Patient Blood Management, by Services USD Million (2022-2027)
  • Table 230. Japan Patient Blood Management, by System USD Million (2022-2027)
  • Table 231. India Patient Blood Management, by Type USD Million (2022-2027)
  • Table 232. India Patient Blood Management, by Application USD Million (2022-2027)
  • Table 233. India Patient Blood Management, by Components USD Million (2022-2027)
  • Table 234. India Patient Blood Management, by Services USD Million (2022-2027)
  • Table 235. India Patient Blood Management, by System USD Million (2022-2027)
  • Table 236. South Korea Patient Blood Management, by Type USD Million (2022-2027)
  • Table 237. South Korea Patient Blood Management, by Application USD Million (2022-2027)
  • Table 238. South Korea Patient Blood Management, by Components USD Million (2022-2027)
  • Table 239. South Korea Patient Blood Management, by Services USD Million (2022-2027)
  • Table 240. South Korea Patient Blood Management, by System USD Million (2022-2027)
  • Table 241. Taiwan Patient Blood Management, by Type USD Million (2022-2027)
  • Table 242. Taiwan Patient Blood Management, by Application USD Million (2022-2027)
  • Table 243. Taiwan Patient Blood Management, by Components USD Million (2022-2027)
  • Table 244. Taiwan Patient Blood Management, by Services USD Million (2022-2027)
  • Table 245. Taiwan Patient Blood Management, by System USD Million (2022-2027)
  • Table 246. Australia Patient Blood Management, by Type USD Million (2022-2027)
  • Table 247. Australia Patient Blood Management, by Application USD Million (2022-2027)
  • Table 248. Australia Patient Blood Management, by Components USD Million (2022-2027)
  • Table 249. Australia Patient Blood Management, by Services USD Million (2022-2027)
  • Table 250. Australia Patient Blood Management, by System USD Million (2022-2027)
  • Table 251. Rest of Asia-Pacific Patient Blood Management, by Type USD Million (2022-2027)
  • Table 252. Rest of Asia-Pacific Patient Blood Management, by Application USD Million (2022-2027)
  • Table 253. Rest of Asia-Pacific Patient Blood Management, by Components USD Million (2022-2027)
  • Table 254. Rest of Asia-Pacific Patient Blood Management, by Services USD Million (2022-2027)
  • Table 255. Rest of Asia-Pacific Patient Blood Management, by System USD Million (2022-2027)
  • Table 256. Europe Patient Blood Management, by Country USD Million (2022-2027)
  • Table 257. Europe Patient Blood Management, by Type USD Million (2022-2027)
  • Table 258. Europe Patient Blood Management, by Application USD Million (2022-2027)
  • Table 259. Europe Patient Blood Management, by Components USD Million (2022-2027)
  • Table 260. Europe Patient Blood Management, by Services USD Million (2022-2027)
  • Table 261. Europe Patient Blood Management, by System USD Million (2022-2027)
  • Table 262. Germany Patient Blood Management, by Type USD Million (2022-2027)
  • Table 263. Germany Patient Blood Management, by Application USD Million (2022-2027)
  • Table 264. Germany Patient Blood Management, by Components USD Million (2022-2027)
  • Table 265. Germany Patient Blood Management, by Services USD Million (2022-2027)
  • Table 266. Germany Patient Blood Management, by System USD Million (2022-2027)
  • Table 267. France Patient Blood Management, by Type USD Million (2022-2027)
  • Table 268. France Patient Blood Management, by Application USD Million (2022-2027)
  • Table 269. France Patient Blood Management, by Components USD Million (2022-2027)
  • Table 270. France Patient Blood Management, by Services USD Million (2022-2027)
  • Table 271. France Patient Blood Management, by System USD Million (2022-2027)
  • Table 272. Italy Patient Blood Management, by Type USD Million (2022-2027)
  • Table 273. Italy Patient Blood Management, by Application USD Million (2022-2027)
  • Table 274. Italy Patient Blood Management, by Components USD Million (2022-2027)
  • Table 275. Italy Patient Blood Management, by Services USD Million (2022-2027)
  • Table 276. Italy Patient Blood Management, by System USD Million (2022-2027)
  • Table 277. United Kingdom Patient Blood Management, by Type USD Million (2022-2027)
  • Table 278. United Kingdom Patient Blood Management, by Application USD Million (2022-2027)
  • Table 279. United Kingdom Patient Blood Management, by Components USD Million (2022-2027)
  • Table 280. United Kingdom Patient Blood Management, by Services USD Million (2022-2027)
  • Table 281. United Kingdom Patient Blood Management, by System USD Million (2022-2027)
  • Table 282. Netherlands Patient Blood Management, by Type USD Million (2022-2027)
  • Table 283. Netherlands Patient Blood Management, by Application USD Million (2022-2027)
  • Table 284. Netherlands Patient Blood Management, by Components USD Million (2022-2027)
  • Table 285. Netherlands Patient Blood Management, by Services USD Million (2022-2027)
  • Table 286. Netherlands Patient Blood Management, by System USD Million (2022-2027)
  • Table 287. Rest of Europe Patient Blood Management, by Type USD Million (2022-2027)
  • Table 288. Rest of Europe Patient Blood Management, by Application USD Million (2022-2027)
  • Table 289. Rest of Europe Patient Blood Management, by Components USD Million (2022-2027)
  • Table 290. Rest of Europe Patient Blood Management, by Services USD Million (2022-2027)
  • Table 291. Rest of Europe Patient Blood Management, by System USD Million (2022-2027)
  • Table 292. MEA Patient Blood Management, by Country USD Million (2022-2027)
  • Table 293. MEA Patient Blood Management, by Type USD Million (2022-2027)
  • Table 294. MEA Patient Blood Management, by Application USD Million (2022-2027)
  • Table 295. MEA Patient Blood Management, by Components USD Million (2022-2027)
  • Table 296. MEA Patient Blood Management, by Services USD Million (2022-2027)
  • Table 297. MEA Patient Blood Management, by System USD Million (2022-2027)
  • Table 298. Middle East Patient Blood Management, by Type USD Million (2022-2027)
  • Table 299. Middle East Patient Blood Management, by Application USD Million (2022-2027)
  • Table 300. Middle East Patient Blood Management, by Components USD Million (2022-2027)
  • Table 301. Middle East Patient Blood Management, by Services USD Million (2022-2027)
  • Table 302. Middle East Patient Blood Management, by System USD Million (2022-2027)
  • Table 303. Africa Patient Blood Management, by Type USD Million (2022-2027)
  • Table 304. Africa Patient Blood Management, by Application USD Million (2022-2027)
  • Table 305. Africa Patient Blood Management, by Components USD Million (2022-2027)
  • Table 306. Africa Patient Blood Management, by Services USD Million (2022-2027)
  • Table 307. Africa Patient Blood Management, by System USD Million (2022-2027)
  • Table 308. North America Patient Blood Management, by Country USD Million (2022-2027)
  • Table 309. North America Patient Blood Management, by Type USD Million (2022-2027)
  • Table 310. North America Patient Blood Management, by Application USD Million (2022-2027)
  • Table 311. North America Patient Blood Management, by Components USD Million (2022-2027)
  • Table 312. North America Patient Blood Management, by Services USD Million (2022-2027)
  • Table 313. North America Patient Blood Management, by System USD Million (2022-2027)
  • Table 314. United States Patient Blood Management, by Type USD Million (2022-2027)
  • Table 315. United States Patient Blood Management, by Application USD Million (2022-2027)
  • Table 316. United States Patient Blood Management, by Components USD Million (2022-2027)
  • Table 317. United States Patient Blood Management, by Services USD Million (2022-2027)
  • Table 318. United States Patient Blood Management, by System USD Million (2022-2027)
  • Table 319. Canada Patient Blood Management, by Type USD Million (2022-2027)
  • Table 320. Canada Patient Blood Management, by Application USD Million (2022-2027)
  • Table 321. Canada Patient Blood Management, by Components USD Million (2022-2027)
  • Table 322. Canada Patient Blood Management, by Services USD Million (2022-2027)
  • Table 323. Canada Patient Blood Management, by System USD Million (2022-2027)
  • Table 324. Mexico Patient Blood Management, by Type USD Million (2022-2027)
  • Table 325. Mexico Patient Blood Management, by Application USD Million (2022-2027)
  • Table 326. Mexico Patient Blood Management, by Components USD Million (2022-2027)
  • Table 327. Mexico Patient Blood Management, by Services USD Million (2022-2027)
  • Table 328. Mexico Patient Blood Management, by System USD Million (2022-2027)
  • Table 329. Research Programs/Design for This Report
  • Table 330. Key Data Information from Secondary Sources
  • Table 331. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Patient Blood Management: by Type USD Million (2016-2021)
  • Figure 5. Global Patient Blood Management: by Application USD Million (2016-2021)
  • Figure 6. Global Patient Blood Management: by Components USD Million (2016-2021)
  • Figure 7. Global Patient Blood Management: by Services USD Million (2016-2021)
  • Figure 8. Global Patient Blood Management: by System USD Million (2016-2021)
  • Figure 9. South America Patient Blood Management Share (%), by Country
  • Figure 10. Asia Pacific Patient Blood Management Share (%), by Country
  • Figure 11. Europe Patient Blood Management Share (%), by Country
  • Figure 12. MEA Patient Blood Management Share (%), by Country
  • Figure 13. North America Patient Blood Management Share (%), by Country
  • Figure 14. Global Patient Blood Management share by Players 2021 (%)
  • Figure 15. Global Patient Blood Management share by Players (Top 3) 2021(%)
  • Figure 16. Global Patient Blood Management share by Players (Top 5) 2021(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. B. Braun (Germany) Revenue, Net Income and Gross profit
  • Figure 19. B. Braun (Germany) Revenue: by Geography 2021
  • Figure 20. Haemonetics Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 21. Haemonetics Corporation (United States) Revenue: by Geography 2021
  • Figure 22. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 23. Terumo Corporation (Japan) Revenue: by Geography 2021
  • Figure 24. Mediware Information Systems (United States) Revenue, Net Income and Gross profit
  • Figure 25. Mediware Information Systems (United States) Revenue: by Geography 2021
  • Figure 26. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2021
  • Figure 28. LivaNova, PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. LivaNova, PLC (United Kingdom) Revenue: by Geography 2021
  • Figure 30. Stratec Biomedical Systems (Diatron) (Germany) Revenue, Net Income and Gross profit
  • Figure 31. Stratec Biomedical Systems (Diatron) (Germany) Revenue: by Geography 2021
  • Figure 32. Accumen Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Accumen Inc. (United States) Revenue: by Geography 2021
  • Figure 34. BioMerieux (France) Revenue, Net Income and Gross profit
  • Figure 35. BioMerieux (France) Revenue: by Geography 2021
  • Figure 36. Asahi Kasei Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 37. Asahi Kasei Corporation (Japan) Revenue: by Geography 2021
  • Figure 38. Grifols, S.A. (Spain) Revenue, Net Income and Gross profit
  • Figure 39. Grifols, S.A. (Spain) Revenue: by Geography 2021
  • Figure 40. Immucor, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 41. Immucor, Inc. (United States) Revenue: by Geography 2021
  • Figure 42. Global Patient Blood Management: by Type USD Million (2022-2027)
  • Figure 43. Global Patient Blood Management: by Application USD Million (2022-2027)
  • Figure 44. Global Patient Blood Management: by Components USD Million (2022-2027)
  • Figure 45. Global Patient Blood Management: by Services USD Million (2022-2027)
  • Figure 46. Global Patient Blood Management: by System USD Million (2022-2027)
  • Figure 47. South America Patient Blood Management Share (%), by Country
  • Figure 48. Asia Pacific Patient Blood Management Share (%), by Country
  • Figure 49. Europe Patient Blood Management Share (%), by Country
  • Figure 50. MEA Patient Blood Management Share (%), by Country
  • Figure 51. North America Patient Blood Management Share (%), by Country
List of companies from research coverage that are profiled in the study
  • B. Braun (Germany)
  • Haemonetics Corporation (United States)
  • Terumo Corporation (Japan)
  • Mediware Information Systems (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • LivaNova, PLC (United Kingdom)
  • Stratec Biomedical Systems (Diatron) (Germany)
  • Accumen Inc. (United States)
  • BioMerieux (France)
  • Asahi Kasei Corporation (Japan)
  • Grifols, S.A. (Spain)
  • Immucor, Inc. (United States)
Additional players considered in the study are as follows:
Kawasumi Laboratories, Inc. (Japan) , Fresenius SE & Co. KGaA (Germany)
Select User Access Type

Key Highlights of Report


Jul 2022 158 Pages 82 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Patient Blood Management Market Quantitative research analysis
Global Patient Blood Management Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as B. Braun (Germany), Haemonetics Corporation (United States), Terumo Corporation (Japan), Mediware Information Systems (United States), Bio-Rad Laboratories, Inc. (United States), LivaNova, PLC (United Kingdom), Stratec Biomedical Systems (Diatron) (Germany), Accumen Inc. (United States), BioMerieux (France), Asahi Kasei Corporation (Japan), Grifols, S.A. (Spain) and Immucor, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"The Increasing Trend of Remote Patient Monitoring in Patient Blood Management " is seen as one of major influencing trends for Patient Blood Management Market during projected period 2021-2027.
The Patient Blood Management market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Patient Blood Management Market Report?

Have a Query? Click Here

Other Related Reports

Sexually Transmitted Disease Treatment Comprehensive Study by Type (Chlamydia, Gonorrhea, Syphilis, Hepatitis B, Genital herpes, HIV/AIDS, Human Papillomavirus, Crabs/Pubic Lice, Others), Application...
$ 3750
Patient Lifting Equipment Comprehensive Study by Type (Ceiling/Overhead Lift, Stair Lift, Sit to Stand Lift, Bath & Pool Lift), Operations (Electric, Manual, Hydraulic), Installation (Mobile, Fixed)...
$ 3450
Pediatric Home Healthcare Services Comprehensive Study by Type (Skilled Nursing Services, Personal Care Assistance, Rehabilitation Therapy Services), Application (Medical Treatment, Preventive Health...
$ 3500
Targeted Delivery Drugs Comprehensive Study by Application (Hospital, Clinic, Others), Technology (Nanoparticles, Polymers (Micelles, Dendrimers), Monoclonal Antibodies, Gold Nanoparticles-Based Drug...
$ 3750
Cardiac Safety Services Comprehensive Study by Type (Integrated Services, Standalone Services), Application (Clinical Trials, Detection and diagnostic, Medical treatment), Patient Type (Infant and ch...
$ 3750
IVD Antibodies Comprehensive Study by Type (Cardiac Markers, Tumor Markers, Kidney Injury Markers, Infection and Inflammation Antibodies), Application (Immunology, Cancer, Cardiovascular Diseases), E...
$ 3500